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Abstracts / Osteoarthritis and Cartilage 22 (2014) S57–S489S160b-glycerophosphate, and 10 mg/mL ascorbic acid) for 2 weeks. To assess
their hypertrophic differentiation, we quantitated markers of hyper-
trophic chondrocytes by real-time RT-PCR and performed ALP and
Alizarin red S stainings. For in vivo analyses, we created a surgically
induced OA model by resecting the medial collateral ligament and the
medial meniscus in the knee joints of 8-week-old mice. Intraarticular
administration of DAPT was performed twice a week for 10 weeks after
surgical induction. For each administration, we injected 10 mL of 2.5 mM
DAPT solution, which was prepared by diluting 25 mM DAPT in DMSO
with PBS at 1:10,000. OA severity was quantiﬁed by the OARSI histo-
pathology grade 10 weeks after surgery. Expressions of marker proteins
were determined by immunoﬂuorescence.
Results: In the primary culture of mouse articular chondrocytes with
differentiation medium, DAPT treatment suppressed expression of
Mmp13, Vegfa, and Hes1 and inhibited mineralization in a dose-
dependent manner, while it induced Col2a1 expression. These results
were compatible with those from the Notch ICD overexpression
experiments. Intraarticular administration of DAPT inhibited articular
cartilage degradation of the mouse experimental OA model. OARSI
grading conﬁrmed that DAPT caused signiﬁcant resistance to OA pro-
gression. Immunoﬂuorescence showed reduced expression of Mmp13,
Vegfa and Hes1 in the articular carilage with DAPT administration.
Conclusion: Inhibition of Notch signaling by intraarticular admin-
istration of DAPT prevents OA progression in the mouse experimental
model. Notch-related molecules including the Notch ligands, Adam and
g-secretase may be candidate therapeutic targets for OA prevention.
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WNT16 SUPPORTS THE PHENOTYPE OF THE SUPERFICIAL ZONE
CELLS IN CARTILAGE
B.L. Thomas y, G. Nalesso y, J. Sherwood y, J. Bertrand z, P. Achan x,
C. Pitzalis y, F. Dell’Accio y. yWilliam Harvey Res. Inst., Barts and the
London Sch. of Med. and Dentistry, London, United Kingdom; z Inst. for
Experimental Musculoskeletal Med., Univ. Hosp. Munster, Munster,
Germany; xDept. of Orthopaedics, St. Bartholomew’s and The Royal
London Hosp., London, United Kingdom
Purpose: During embryonic skeletogenesis WNT16 is a speciﬁc marker
of the joint interzone which will give rise to the joint and the perma-
nent articular cartilage. In adult joints WNT16 is no longer expressed,
but it becomes rapidly upregulated in the articular cartilage following
injury and in osteoarthritis (OA).
The superﬁcial zone of the articular cartilage contains chondrogenic
progenitor cells which speciﬁcally express WNT16 and Lubricin and are
essential for the long-term maintenance of cartilage homeostasis.
Lubricin in adulthood is essential for joint lubrication and in its absence,
mice develop spontaneous OA.
This study tests the hypothesis that WNT16 contributes to cartilage
homeostasis following injury by supporting the survival, phenotypic
stability, and function of the superﬁcial zone progenitor cells.
Methods: Superﬁcial zone cells (SZC) were isolated from the knees of
neonatal wnt16-/- and wild-type mice by a sequential digestion with
trypsin and collagenase followed by a selection procedure based onadhesion to ﬁbronectin. Deep zone chondrocytes (DZC) were obtained
by further digestion of the joints with collagenase overnight.
Results: Upon isolation, in wild type mice, SZC were characterized by
the expression of Lubricin and WNT16 as previously reported, whereas
DZC expressed Matrilin-1. Chondrocyte marker Sox9 and extracellular
matrix components such as Aggrecan and Collagen2A1 were more
expressed in the DZC as expected.
Lubricin expression was decreased in wnt16-/- and heterozygous SZC
compared to those from wild type mice. Exogenous WNT16 dose-
dependently increased Lubricin expression in wnt16-/- SFZ cells and pri-
mary bovine chondrocytes. WNT16 treatment also dose-dependently
increased the canonical target gene Axin2 and correlated with the TOP-
FLASH reporter assay. Importantly, DKK1 prevented the WNT16-induced
Lubricin upregulation, thereby demonstrating thatmodulation of the gene
occurs through the canonical pathway. Interestingly,WNT-3Awas amuch
stronger activator of the canonical WNT pathway, but it hardly activated
Lubricin expression, thereby suggesting that other, yet unknown, aspects
of WNT16 signalling are essential for its capacity to upregulate Lubricin.
Sox9 expression was increased in wnt16-/- SZC and lost upon WNT16
stimulation in these cells as well as bovine primary chondrocytes.
wnt16-/- SZC also had a higher content of sulphated proteoglycans
when cultured in micromass, (as measured with alcian blue).
Therefore WNT16 maintains the progenitor phenotype of superﬁcial
zone cells and in its absence, these cells acquire a phenotype more
similar to that of the deep zone chondrocytes.
Conclusion: We have discovered that WNT16 supports Lubricin
expression through activation of the canonical WNT pathway and that
WNT16 supports the maintenance of the speciﬁc phenotype of the
superﬁcial zone cells.
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HEDGEHOG SIGNALING REGULATES CHOLESTEROL HOMEOSTASIS IN
OSTEOARTHRITIS
S.A. Ali y, H.C. Whetstone z, B.A. Alman x. yUniv. of Toronto, TORONTO,
ON, Canada; zHosp. for Sick Children, TORONTO, ON, Canada; xDuke
Univ., DURHAM, NC, USA
Current evidence suggests thatmechanical, genetic, andmetabolic factors
play a role in the pathogenesis of osteoarthritis (OA). Hedgehog (Hh)
signaling is known to regulate chondrocyte differentiation, and to be
activated in human and murine OA. Since Hh signaling regulates Gli-
mediated gene expression, we identiﬁed Hh target genes that are
expressed in chondrocytes.Microarrayanalyseswere performed to detect
changes in gene expression when the Hh pathway was modulated in
humanOAcartilage samples. Results from theAffymetrixHumanGene1.0
ST microarray were analyzed for differentially expressed genes from ﬁve
patient samples.Using IngenuityPathwayanalysis, several genesknown
tobe involved in sterolhomeostasiswere found tobeupregulatedwithHh
inhibition. To investigate the function of these genes in cartilage, mice
with chondrocyte-speciﬁc cholesterol accumulationwere generated. This
was achieved by excising Insig1 and Insig2, major negative regulators of
cholesterol homeostasis, under Col2a1 regulatoryelements.With agingor
surgically induced joint instability, mice with chondrocyte-speciﬁc cho-
lesterol accumulation developedmore severe OA than control littermates.
They expressed markers of chondrocyte hypertrophy in the articular
cartilage, including typeX collagen. Statin treatment to inhibit cholesterol
production rescued this phenotype and reduced the severity of OA.
Genetic manipulation of Hedgehog signaling in these mice suggests that
Hh signaling is modulating the phenotype by regulating sterol homeo-
stasis. Here we identiﬁed novel Hh target genes in chondrocytes that
regulate intracellular cholesterol levels, and found that cholesterol dys-
regulation in the chondrocytes predisposes to OA. These data suggest that
pharmacologic correction of intra-articular sterol imbalance can be used
as a treatment for osteoarthritis.
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EXPRESSION AND FUNCTION OF CCAAT/ENHANCER-BINDING
PROTEIN FAMILY IN CHONDROCYTES
T. Okuma y, M. Hirata z,y, S. Chang y, K. Okada y, Y. Mori y,
H. Kobayashi y, S. Sugita y, S. Tanaka y, H. Kawaguchi y,x, T. Saito y,k.
y Sensory and Motor System Med., Faculty of Med., Univ. of Tokyo, Tokyo,
Japan; zHosp. for Sick Children, Toronto, ON, Canada; x Spine and Spinal
Cord Ctr., Tokyo Kosei Nenkin Hosp., Tokyo, Japan; kBone and Cartilage
Regenerative Med., Faculty of Med., Univ. of Tokyo, Tokyo, Japan
Abstracts / Osteoarthritis and Cartilage 22 (2014) S57–S489 S161Purpose: CCAAT/enhancer-binding protein (C/EBP) is a member of the
leucine zipper family of transcription factors. Among six isoforms of C/
EBP family members, C/EBPa, C/EBPb, C/EBPd and C/EBPε have a
transactivation domain and exert redundant functions in many phys-
iological processes such as cell differentiation, cell proliferation, cell
cycle regulation, inﬂammation and immunity. We previously reported
that C/EBPb is abundantly expressed in chondrocytes and regulates
skeletal growth and osteoarthritis through the induction of cell cycle-
related genes and metalloproteinases. Since the roles of C/EBPa, C/EBPd
and C/EBPε remain unclear, the present study examined expressions
and functions of these C/EBPs in chondrocytes.
Methods: We examined expression levels of the four C/EBPs with
transactivation domains in mouse primary costal chondrocytes by real-
time RT-PCR, and their expression patterns in mouse embryonic limb
cartilage by immunohistochemistry. Transcriptional regulation of rep-
resentative marker gene promoters was assessed by luciferase assay
using HeLa cells transfected with a reporter construct and the expres-
sion vector of each C/EBP. For gain-of-function analyses, each C/EBP was
introduced into mouse chondrogenic cell line ATDC5 by retroviral
vector. For loss-of-function analyses, we prepared A-C/EBP, a designed
dominant-negative construct that can heterodimerize with all C/EBPs
and abolish their DNA binding abilities. We conﬁrmed the protein-
protein binding with A-C/EBP and C/EBPs by mammalian two-hybrid
assay and co-immunoprecipitation assay, and the dominant-negative
effect of A-C/EBP by co-transfectionwith C/EBPs in luciferase assay. A-C/
EBP was introduced into ATDC5 cells by lentiviral vector. To further
investigate entire functions of the C/EBP family, we performed cDNA
microarray analyses using the RNA samples of A-C/EBP or GFP over-
expressing cells. Genes upregulated or downregulated more than twice
by A-C/EBP overexpression were identiﬁed using Genespring software.
Results: Among the four C/EBPs with the transactivation domains,
expression of C/EBPb and C/EBPd in mouse primary costal chondrocytes
was abundant compared to C/EBPa, while C/EBPεwashardly expressed. In
mouse embryonic limb cartilage, C/EBPb and C/EBPd proteins were pre-
dominantly localized in the prehypertrophic and hypertrophic zones,
while C/EBPa protein was localized in the proliferative zone. All three C/
EBPs stimulated promoter activities of matrix metalloproteinase-13
(MMP13) and vascular endothelial growth factor A (VEGFA) genes. Ret-
roviral overexpression of each of the three C/EBPs in ATDC5 cells sup-
pressed expressions of early differentiationmarkers including Col2a1 and
Sox9, and enhanced those of late differentiation markers including
Mmp13andVegfa. Thepresent data imply thatC/EBPb, C/EBPd andC/EBPa
have redundant function in chondrocytes and may compensate each
other. To investigate loss-of-functionof the threeC/EBPs,weusedA-C/EBP
which exerts a dominant-negative effect against all C/EBPs. We ﬁrst
conﬁrmed that A-C/EBP could bind with all three C/EBPs by mammalian
two-hybrid assay and co-immunoprecipitation assay. The A-C/EBP
transfection reduced the enhancement of MMP13 and VEGFA promoter
activities by the three C/EBPs in a dose-dependent manner. When we
introduced A-C/EBP into ATDC5 cells by lentiviral vector, expressions of
Col2a1 and Sox9 were increased, and those of Mmp13 and Vegfa were
decreased, conﬁrming that these three C/EBPs suppress the early stage of
chondrocyte differentiation while enhancing the late stage. Finally, gen-
eontology analyses based on the cDNA microarray data identiﬁed many
genes regulated by the A-C/EBP overexpression: 19, 17, 35 and 13 genes
were upregulated while 26, 41, 97 and 62 genes were downregulated in
the skeletal development-related, cell cycle-related, apoptosis-related,
and inﬂammation-related gene groups, respectively.
Conclusions: C/EBPb, C/EBPd and C/EBPa were expressed in chon-
drocytes, and regulate proliferation and differentiation of chondrocytes.
The loss-of-function analyses by A-C/EBP also suggests the involvement
of the C/EBPs in apoptosis and inﬂammation. These results suggest that
C/EBPs may play a variety of roles in the homeostasis of joint cartilage
under physiological and pathological conditions.
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TRANSCRIPTIONAL REGULATION OF THE NON-CODING SNORNA
RMRP DURING CHONDROGENIC DIFFERENTIATION; A ROLE FOR
NFlB/P65?
M.M. Steinbusch y, M.M. Caron y, F. Eckmann z, E. Lausch z,
L.W. van Rhijn y, B. Zabel z, T.J. Welting y. yDept. of Orthopaedic Surgery.
Maastricht Univ. Med. Ctr., Maastricht, Netherlands; zCtr. for Paediatrics
and Adolescent Med., Univ. of Freiburg, Freiburg, GermanyPurpose: The ribonuclease mitochondrial RNA processing (RMRP)
gene encodes the non-coding RNA component of a multi-protein-
RNA complex called RNase MRP. This small nucleolar ribonucleo-
protein particle is implicated in various cellular processes, including
ribosomal biogenesis, mitochondrial RNA cleavage, cell cycle regu-
lation and has been linked to telomerase. Mutations in the RMRP
gene cause Cartilage Hair Hypoplasia (CHH). The main phenotypic
hallmark of CHH is dwarﬁsm. In agreement with a pivotal role in
determining chondrogenic cell fate, we have previously found that
RMRP expression is predominantly associated with chondrocyte
hypertrophy and that RNAi-mediated knockdown (KD) of RMRP RNA
leads to deregulation of the chondrogenic differentiation program of
ATDC5 cells. Importantly, we could also conﬁrm that chondrogenic
transdifferentiation of CHH patient-derived ﬁbroblasts was impaired.
Our most recent ﬁndings indicate that bone morphogenic protein 2
(BMP-2) signaling may be involved in regulating transcription of the
RMRP gene, thereby connecting RMRP expression to important
chondrogenic signaling networks. As BMP-2 is known to activate
NFlB/p65 and chondrocyte hypertrophy is associated with similar
cell stress-signaling, we hypothesized that NFlB/p65 acts as a tran-
scriptional activator of RMRP gene expression during chondrogenic
differentiation.
Methods: RMRP, p65 or Bapx1/Nkx3.2 expression was targeted in
ATDC5 or SW1353 cells by transfection of custom-made speciﬁc
siRNA duplexes. Gene expression was analyzed by RT-qPCR. In silico
analyses of the murine and human RMRP promoter was performed
on the -600 bp proximal promoters using MatInspector from
Genomatix. SW1353 cells (either mock transfected or Bapx1/Nkx3.2
KD) were exposed to human IL-1b (10 ng/ml) or human TNF-a (20
ng/ml) for 2 days.
Results: To investigate how RMRP is implicated in chondrogenic
differentiation, we genetically targeted RMRP expression using RNAi
in ATDC5 cells. KD of RMRP expression caused deregulation of
chondrogenic differentiation, characterized by signiﬁcantly reduced
expression of Sox9, Col2a1, Runx2 and Col10a1 mRNAs. Interestingly,
KD of RMRP expression resulted in signiﬁcantly increased expression
of the hypertrophic repressor Bapx1/Nkx3.2, suggesting a potential
role for RMRP in determining the hypertrophic differentiation fate.
Conﬁrming a close connection with hypertrophic differentiation,
BMP-2 (not BMP-7) was speciﬁcally able to increase the expression
of RMRP in ATDC5 cells. BMP-2 is known to activate NFlB/p65 and
chondrocyte hypertrophy is associated with similar cell stress-sig-
naling. Therefore we further investigated the relation between RMRP,
p65 and hypertrophic differentiation. To determine whether NFlB/
p65 may be involved in transcription of RMRP, the expression of p65
mRNA was targeted by transfection of speciﬁc siRNA duplexes. KD of
p65 mRNA expression indeed resulted in signiﬁcant downregulation
of RMRP expression in ATDC5 cells. In silico analyses for the pres-
ence of transcription factor binding sites in the murine and human
RMRP proximal promoters predicted the conserved presence of
putative NFlB binding sites. Complementary to above p65 RNAi, we
exposed SW1353 chondrosarcoma cells to NFlB/p65 activating
cytokines IL1b or TNFa and determined whether RMRP expression
responded to NFlB/p65 activation. The expression of RMRP did not
respond signiﬁcantly to exposure to IL1b or TNFa. Subsequently, to
force cells into hypertrophic signaling, we interfered with Bapx1/
Nkx3.2 expression by RNAi. Indeed cells acquired an increased
hypertrophic phenotype, but RMRP expression was not affected.
Surprisingly, when Nkx3.2/Bapx1 KD cells were exposed to similar
IL1b or TNFa conditions, the expression of RMRP increased
drastically.
Conclusions: These data show that RMRP expression levels determine
chondrogenic differentiation fate and suggest that RMRP expression
may depend on NFlB/p65. However, activation of NFlB/p65 by IL1b or
TNFa alone was found not to be sufﬁcient for induction of RMRP
expression. In contrast, forced hypertrophic differentiation by Bapx1/
Nkx3.2 KD in the presence of IL1b or TNFa was speciﬁcally able to
increase RMRP expression, which is in agreement with the BMP-2-
induced RMRP expression. We thus conclude that RMRP exerts crucial
regulatory functions required for chondrogenic differentiation and our
current efforts are focused on elucidating which function of RNase MRP
is predominantly involved in chondrogenic differentiation, as well as
further establishing NFlB/p65 as a transcription factor for RMRP gene
expression.
